N-(3-(1-(6-((2-(dimethylamino)benzyl)(ethyl)amino)hexyl)-6-oxo-1,6-dihydropyridazin-3-yl)-4-hydroxyphenyl)acetamide

ID: ALA5179810

Chembl Id: CHEMBL5179810

PubChem CID: 168273802

Max Phase: Preclinical

Molecular Formula: C29H39N5O3

Molecular Weight: 505.66

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CCCCCCn1nc(-c2cc(NC(C)=O)ccc2O)ccc1=O)Cc1ccccc1N(C)C

Standard InChI:  InChI=1S/C29H39N5O3/c1-5-33(21-23-12-8-9-13-27(23)32(3)4)18-10-6-7-11-19-34-29(37)17-15-26(31-34)25-20-24(30-22(2)35)14-16-28(25)36/h8-9,12-17,20,36H,5-7,10-11,18-19,21H2,1-4H3,(H,30,35)

Standard InChI Key:  PNJAZXJXBGGURX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5179810

    ---

Associated Targets(Human)

APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNE Tclin Acetylcholine receptor protein epsilon chain (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.66Molecular Weight (Monoisotopic): 505.3053AlogP: 4.72#Rotatable Bonds: 13
Polar Surface Area: 90.70Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.56CX Basic pKa: 9.47CX LogP: 3.22CX LogD: 2.27
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.26Np Likeness Score: -1.52

References

1. Shi Y, Zhang H, Song Q, Yu G, Liu Z, Zhong F, Tan Z, Liu X, Deng Y..  (2022)  Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease.,  230  [PMID:35026532] [10.1016/j.ejmech.2021.114098]

Source